| 臺大學術典藏 |
2022-09-15T05:42:28Z |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
Sun H.-Y.; Cheng C.-Y.; Lin C.-Y.; Yang C.-J.; Lee N.-Y.; Liou B.-H.; Tang H.-J.; Liu Y.-M.; Lee C.-Y.; Chen T.-C.; Huang Y.-C.; Lee Y.-T.; Tsai M.-J.; Lu P.-L.; Tsai H.-C.; Wang N.-C.; Hung T.-C.; Cheng S.-H.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-09-07T06:39:25Z |
Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: Incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia
|
Yang J.-J.; Huang C.-H.; Liu C.-E.; Tang H.-J.; Yang C.-J.; Lee Y.-C.; Lee K.-Y.; Tsai M.-S.; SHU-WEN LIN; Chen Y.-H.; Lu P.-L.; Hung C.-C. |
| 臺大學術典藏 |
2022-06-20T05:55:14Z |
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019
|
Tsai Y.-T.; Lee Y.-L.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Hsueh P.-R. |
| 國立成功大學 |
2022 |
Economic feasibility assessment of cage aquaculture in offshore wind power generation areas in Changhua County, Taiwan
|
Huang, C.-T.;Afero, F.;Hung, C.-W.;Chen, B.-Y.;Nan, F.-H.;Chiang, W.-S.;Tang, H.-J.;Kang, C.-K. |
| 國立成功大學 |
2022 |
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodst
|
Liu, P.-Y.;Ko, W.-C.;Lee, W.-S.;Lu, P.-L.;Chen, Y.-H.;Cheng, S.-H.;Lu, M.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Shao, P.-L.;Lee, Y.-L.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Lin, C.-N.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Tang, H.-J.;Hsueh, P.-R. |
| 國立成功大學 |
2022 |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
Sun, H.-Y.;Cheng, Cheng C.-Y.;Lin, C.-Y.;Yang, C.-J.;Lee, N.-Y.;Liou, B.-H.;Tang, H.-J.;Liu, Y.-M.;Lee, C.-Y.;Chen, T.-C.;Huang, Y.-C.;Lee, Y.-T.;Tsai, M.-J.;Lu, P.-L.;Tsai, H.-C.;Wang, N.-C.;Hung, T.-C.;Cheng, S.-H.;Hung, C.-C. |
| 國立成功大學 |
2022 |
Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials
|
Lee, M.-C.;Hua, Y.-M.;Yang, C.-T.;Kuo, F.-H.;Chang, W.-T.;Tang, H.-J.;Siong, Toh H.;Lin, Y.-M.;Chen, S.-Y.;Chang, H.-Y.;Liao, C.-T. |
| 國立成功大學 |
2022 |
Experimental and numerical studies on successive failures of two mooring lines of a net cage subjected to currents
|
Tang, H.-J.;Yao, H.-C.;Yang, R.-Y. |
| 國立成功大學 |
2022 |
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019
|
Tsai, Y.-T.;Lee, Y.-L.;Lu, M.-C.;Shao, P.-L.;Lu, P.-L.;Cheng, S.-H.;Ko, W.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Lee, W.-S.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Lin, C.-N.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Tang, H.-J.;Lin, C.-Y.;Chen, Y.-H.;Hsueh, P.-R. |
| 國立成功大學 |
2022 |
NUMERICAL STUDY of AN ALTERNATIVE WAY of EVALUATING the REMAINING VOLUME of A FISH CAGE
|
Tang, H.-J.;Yeh, P.-H.;Yang, R.-Y.;Nan, F.-H. |
| 臺大學術典藏 |
2021-12-01T02:29:11Z |
Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia
|
Huang Y.-S.; Liu C.-E.; Lin S.-P.; Lee C.-H.; Yang C.-J.; Lin C.-Y.; Tang H.-J.; Lee Y.-C.; Lin Y.-C.; Lee Y.-T.; Sun H.-Y.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2021-12-01T02:29:09Z |
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study
|
Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; Lin K.-Y.; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; CHIEN-CHING HUNG; Wang N.-C.; for the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-09-27T05:32:42Z |
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019
|
Tsai Y.-T.; Lee Y.-L.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Lin C.-Y.; Chen Y.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:41Z |
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
|
Liu P.-Y.; Ko W.-C.; Lee W.-S.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Lu M.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Shao P.-L.; Lee Y.-L.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:37Z |
In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017–2020
|
Lee Y.-L.; Ko W.-C.; Lee W.-S.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Lu M.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Shao P.-L.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-08-27T06:48:54Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:54Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:50Z |
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study
|
Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; KUAN-YIN LIN; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; Hung C.-C.; Wang N.-C.; for the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:47Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; KUAN-YIN LIN; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; Huang Y.-S.; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:46Z |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Lee Y.-L.; KUAN-YIN LIN; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:13Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:13Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:07Z |
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study
|
Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; KUAN-YIN LIN; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; Hung C.-C.; Wang N.-C.; for the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:03Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; KUAN-YIN LIN; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; Huang Y.-S.; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:02Z |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Lee Y.-L.; KUAN-YIN LIN; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
